However, a randomized, double-blind, placebo-controlled study showed a trend toward fewer and milder rejections during the first 6 months in the rituximab group with no increase in infectious complications [ 5 ].
← all excerpts
Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab.
1
—
—